US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Lack of Assurance of Sterility

SCA Pharmaceuticals, LLC NDC 70004-0231-32 D-0397-2024
Class II · Moderate risk Terminated

fentaNYL 2

Reason Lack of Assurance of Sterility

SCA Pharmaceuticals, LLC NDC 70004-0222-30 D-0396-2024
Class II · Moderate risk Terminated

fentaNYL 2

Reason Lack of Assurance of Sterility

SCA Pharmaceuticals, LLC NDC 70004-0229-40 D-0395-2024
Class III · Low risk Terminated

LET Gel

Reason Product Mix-up: Incorrect Product Formulation

Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop NDC 73271-1003-1 D-0140-2024
Class II · Moderate risk Terminated

Oxygen

Reason cGMP Deviations

Family Medical Supply Inc D-0106-2024
Class I · High risk Ongoing

Dr. Ergin's SugarMD

Reason MARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburide

Sugarmds LLC D-0138-2024
Class II · Moderate risk Ongoing

Naproxen Tablets

Reason Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024
Class II · Moderate risk Ongoing

Indomethacin 25mg Capsules

Reason Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Glenmark Pharmaceuticals Inc., USA NDC 68462-406-01 D-0123-2024
Class I · High risk Terminated

Vitrakvi

Reason Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing

Bayer Healthcare Pharmaceuticals Inc. NDC 50419-392-01 D-0145-2024
Class III · Low risk Terminated

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP

Reason Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Taro Pharmaceuticals Inc. NDC 51672-3007-1 D-0089-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0122-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0121-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0120-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0119-2024
Class I · High risk Ongoing

LEADER brand Lubricant Eye Drops

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0136-2024
Class I · High risk Ongoing

LEADER brand Dry Eye Relief

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0135-2024
Class I · High risk Ongoing

LEADER brand Lubricant Eye Drops

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0134-2024
Class I · High risk Ongoing

LEADER brand Lubricant Eye Drops

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0133-2024
Class I · High risk Ongoing

LEADER brand Dry Eye Relief

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0132-2024
Class I · High risk Ongoing

LEADER brand Eye Irritation Relief

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Cardinal Health Inc. D-0131-2024
Class I · High risk Terminated

Lubricating Tears Eye Drops

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0536-1282-94 D-0108-2024
Class I · High risk Terminated

Polyvinyl Alcohol 1.4% Lubricating Eye Drops

Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0536-1325-94 D-0107-2024
Class III · Low risk Terminated

V-FORCE Homeopathic

Reason Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

Grato Holdings, Inc. D-0099-2024